{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:52Z","timestamp":1761128572848},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p>Disseminated mucormycosis, with pulmonary and cerebral angioinvasive disease, developed in a 65\u2010year\u2010old woman with rheumatoid arthritis being treated with combination immunosuppression including adalimumab. Clinical presentation included progressive orbital ischaemia. To the best of the authors' knowledge, this is the first reported case of disseminated mucormycosis in a patient treated with a tumour necrosis factor inhibitor. Important pathophysiological factors are considered.<\/jats:p>","DOI":"10.1111\/j.1442-9071.2007.01458.x","type":"journal-article","created":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T08:29:23Z","timestamp":1176280163000},"page":"275-280","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Disseminated mucormycosis and orbital ischaemia in combination immunosuppression with a tumour necrosis factor alpha inhibitor"],"prefix":"10.1111","volume":"35","author":[{"given":"Pritpal","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon F","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajmohan","family":"Murali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavier J","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowri L","family":"Kanthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J","family":"Maloof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,11]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1113","volume-title":"Pathology of Infectious Diseases","author":"Chandler FW","year":"1997"},{"key":"e_1_2_6_3_2","unstructured":"GrovesC SaltzJ.Microbiology Newsletter. Department Pathology The Johns Hopkins Medical Institutions 1996;15 (33). Available from:http:\/\/pathology5.pathology.jhmi.edu\/micro\/v15n33.htm"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.397"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.58.2008.i70","article-title":"Preliminary results of early clinical trials with the fully human anti\u2010TNF\u03b1 monoclonal antibody D2E7","volume":"58","author":"Kempeni L.","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000127594.92432.7c"},{"key":"e_1_2_6_7_2","first-page":"2563","article-title":"Adalimumab, a fully human anti tumor necrosis factor\u2010alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)","volume":"30","author":"Furst DE","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10697"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20217"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2004.02.003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410017284"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.12.5999-6003.1998"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","article-title":"Role of TNF alpha in pulmonary host defense in murine invasive aspergillosis","volume":"162","author":"Mehrad B","year":"1999","journal-title":"J Immunol"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2007.01458.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2007.01458.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:42:28Z","timestamp":1696916548000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2007.01458.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1442-9071.2007.01458.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2007.01458.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"2007-04-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}